Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer

Abstract Background Small cell lung cancer (SCLC) has an exceptionally poor prognosis; as most of the cases are initially diagnosed as extensive disease with hematogenous metastasis. Therefore, the early diagnosis of SCLC is very important and may improve its prognosis. Methods To investigate the fe...

Full description

Bibliographic Details
Main Authors: Dong Ha Kim, Hyojeong Park, Yun Jung Choi, Kyungtaek Im, Chae Won Lee, Da-Som Kim, Chan-Gi Pack, Hyun-Yi Kim, Chang-Min Choi, Jae Cheol Lee, Wonjun Ji, Jin Kyung Rho
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-023-00517-1
_version_ 1797557501729701888
author Dong Ha Kim
Hyojeong Park
Yun Jung Choi
Kyungtaek Im
Chae Won Lee
Da-Som Kim
Chan-Gi Pack
Hyun-Yi Kim
Chang-Min Choi
Jae Cheol Lee
Wonjun Ji
Jin Kyung Rho
author_facet Dong Ha Kim
Hyojeong Park
Yun Jung Choi
Kyungtaek Im
Chae Won Lee
Da-Som Kim
Chan-Gi Pack
Hyun-Yi Kim
Chang-Min Choi
Jae Cheol Lee
Wonjun Ji
Jin Kyung Rho
author_sort Dong Ha Kim
collection DOAJ
description Abstract Background Small cell lung cancer (SCLC) has an exceptionally poor prognosis; as most of the cases are initially diagnosed as extensive disease with hematogenous metastasis. Therefore, the early diagnosis of SCLC is very important and may improve its prognosis. Methods To investigate the feasibility of early diagnosis of SCLC, we examined exosomal microRNAs (miRNAs) present in serum obtained from patients with SCLC. First, exosomes were isolated in serum from patients with SCLC and healthy individuals and were characterized using particle size and protein markers. Additionally, miRNA array was performed to define SCLC-specific exosomal miRNAs. Second, the obtained miRNAs were further validated employing a large cohort. Finally, the ability to diagnose SCLC was estimated by area under the curve (AUC), and intracellular mRNA change patterns were verified through validated miRNAs. Results From the miRNA array results, we selected 51-miRNAs based on p-values and top 10 differentially expressed genes, and 25-miRNAs were validated using quantitative reverse transcription-polymerase chain reaction. The 25-miRNAs were further validated employing a large cohort. Among them, 7-miRNAs showed significant differences. Furthermore, 6-miRNAs (miR-3565, miR-3124-5p, miR-200b-3p, miR-6515, miR-3126-3p and miR-9-5p) were up-regulated and 1-miRNA (miR-92b-5p) was down-regulated. The AUC value of each miRNA sets between 0.64 and 0.76, however the combined application of 3-miRNAs (miR-200b-3p, miR-3124-5p and miR-92b-5p) remarkably improved the diagnostic value (AUC = 0.93). Gene ontology analysis revealed that the 3-miRNA panel is linked to various oncogene pathways and nervous system development. When the 3-miRNAs were introduced to cells, the resulting changes in total mRNA expression strongly indicated the presence of lung diseases, including lung cancer. In addition, the 3-miRNA panel was significantly associated with a poorer prognosis, although individual miRNAs have not been validated as prognostic markers. Conclusion Our study identified SCLC-specific exosomal miRNAs, and the 3-miRNAs panel (miR-200b-3p, miR-3124-5p and miR-92b-5p) may serve as a diagnostic and prognostic marker for SCLC. Graphical abstract
first_indexed 2024-03-10T17:17:48Z
format Article
id doaj.art-004a40481b604424bf05974497000327
institution Directory Open Access Journal
issn 2050-7771
language English
last_indexed 2024-03-10T17:17:48Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Biomarker Research
spelling doaj.art-004a40481b604424bf059744970003272023-11-20T10:25:06ZengBMCBiomarker Research2050-77712023-09-0111111410.1186/s40364-023-00517-1Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancerDong Ha Kim0Hyojeong Park1Yun Jung Choi2Kyungtaek Im3Chae Won Lee4Da-Som Kim5Chan-Gi Pack6Hyun-Yi Kim7Chang-Min Choi8Jae Cheol Lee9Wonjun Ji10Jin Kyung Rho11Asan Institute for Life SciencesDepartment of Biomedical Sciences, AMISTAsan Institute for Life SciencesAsan Institute for Life SciencesDepartment of Biomedical Sciences, AMISTDepartment of Biomedical Sciences, AMISTDepartment of Convergence Medicine, University of Ulsan College of MedicineNGeneS IncDepartment of Pulmonary Critical and Care Medicine, University of Ulsan College of MedicineDepartment of Oncology, Asan Medical Center, University of Ulsan College of MedicineDepartment of Pulmonary Critical and Care Medicine, University of Ulsan College of MedicineDepartment of Convergence Medicine, University of Ulsan College of MedicineAbstract Background Small cell lung cancer (SCLC) has an exceptionally poor prognosis; as most of the cases are initially diagnosed as extensive disease with hematogenous metastasis. Therefore, the early diagnosis of SCLC is very important and may improve its prognosis. Methods To investigate the feasibility of early diagnosis of SCLC, we examined exosomal microRNAs (miRNAs) present in serum obtained from patients with SCLC. First, exosomes were isolated in serum from patients with SCLC and healthy individuals and were characterized using particle size and protein markers. Additionally, miRNA array was performed to define SCLC-specific exosomal miRNAs. Second, the obtained miRNAs were further validated employing a large cohort. Finally, the ability to diagnose SCLC was estimated by area under the curve (AUC), and intracellular mRNA change patterns were verified through validated miRNAs. Results From the miRNA array results, we selected 51-miRNAs based on p-values and top 10 differentially expressed genes, and 25-miRNAs were validated using quantitative reverse transcription-polymerase chain reaction. The 25-miRNAs were further validated employing a large cohort. Among them, 7-miRNAs showed significant differences. Furthermore, 6-miRNAs (miR-3565, miR-3124-5p, miR-200b-3p, miR-6515, miR-3126-3p and miR-9-5p) were up-regulated and 1-miRNA (miR-92b-5p) was down-regulated. The AUC value of each miRNA sets between 0.64 and 0.76, however the combined application of 3-miRNAs (miR-200b-3p, miR-3124-5p and miR-92b-5p) remarkably improved the diagnostic value (AUC = 0.93). Gene ontology analysis revealed that the 3-miRNA panel is linked to various oncogene pathways and nervous system development. When the 3-miRNAs were introduced to cells, the resulting changes in total mRNA expression strongly indicated the presence of lung diseases, including lung cancer. In addition, the 3-miRNA panel was significantly associated with a poorer prognosis, although individual miRNAs have not been validated as prognostic markers. Conclusion Our study identified SCLC-specific exosomal miRNAs, and the 3-miRNAs panel (miR-200b-3p, miR-3124-5p and miR-92b-5p) may serve as a diagnostic and prognostic marker for SCLC. Graphical abstracthttps://doi.org/10.1186/s40364-023-00517-1ExosomeExosomal miRNADiagnosisPrognosisSCLC
spellingShingle Dong Ha Kim
Hyojeong Park
Yun Jung Choi
Kyungtaek Im
Chae Won Lee
Da-Som Kim
Chan-Gi Pack
Hyun-Yi Kim
Chang-Min Choi
Jae Cheol Lee
Wonjun Ji
Jin Kyung Rho
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
Biomarker Research
Exosome
Exosomal miRNA
Diagnosis
Prognosis
SCLC
title Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
title_full Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
title_fullStr Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
title_full_unstemmed Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
title_short Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer
title_sort identification of exosomal microrna panel as diagnostic and prognostic biomarker for small cell lung cancer
topic Exosome
Exosomal miRNA
Diagnosis
Prognosis
SCLC
url https://doi.org/10.1186/s40364-023-00517-1
work_keys_str_mv AT donghakim identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT hyojeongpark identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT yunjungchoi identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT kyungtaekim identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT chaewonlee identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT dasomkim identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT changipack identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT hyunyikim identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT changminchoi identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT jaecheollee identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT wonjunji identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer
AT jinkyungrho identificationofexosomalmicrornapanelasdiagnosticandprognosticbiomarkerforsmallcelllungcancer